Why CAS-One IR navigation?
Surgical resection has traditionally been considered as the first line treatment for primary liver cancer and liver metastases. But with only 10% to 20% of cases being suitable for resection (Tanis et al, 2014), alternatives are sorely needed. Improvements in ablation techniques over the last decade have led to an increased number of procedures, and a positive impact progression-free and overall survival in patients has been demonstrated (Ruers et al, 2012, Engstrand et al, 2014). In spite of this, ablation is not without its challenges, which is why we developed CAS-One IR stereotactic support for percutaneous ablation, ensuring precision, efficacy and successful outcomes.
- Increased accuracy helps to improve patient outcomes
- Efficient use of the IR suite due to faster procedure time
- Better planning capabilities regardless of complexity of case
- Less exposure to radiation for patient and operator compared to non-navigated procedures
- New option for patients previously considered ‘untreatable’ with resection or non-guided ablation
- Ensures precise, repeatable procedures for operators of all levels of experience